StockWatch
·
Medical/Dental Instruments
RegulatoryMay 8, 2026, 06:14 AM

Profusa Granted Nasdaq Listing Exception with Conditions

AI Summary

Profusa, Inc. announced that it received a decision letter from the Nasdaq Hearings Panel on May 6, 2026, granting an exception to continue its listing on Nasdaq. This exception is contingent upon the company meeting specific interim milestones and complying with Nasdaq's Bid Price Rule and Equity Rule by July 6, 2026. Profusa is currently evaluating these conditions and intends to take necessary actions to achieve compliance, though there is no assurance it will be able to do so.

Key Highlights

  • Profusa received a decision letter from the Nasdaq Hearings Panel on May 6, 2026.
  • The company was granted an exception to continue its listing on Nasdaq.
  • Continued listing is subject to meeting certain interim milestones.
  • Profusa must comply with Nasdaq Listing Rule 5550(a)(2) (Bid Price Rule) by July 6, 2026.
  • Profusa must comply with Nasdaq Listing Rule 5550(b)(2) (Equity Rule) by July 6, 2026.
  • The company is evaluating the conditions and intends to seek compliance.
  • There is no assurance that Profusa will be able to meet all applicable listing criteria.